2898-13-7
2898-13-7
Chemical Structure
Sulazepam
- CAS No.: 2898-13-7
- Formula:C16H13ClN2S
- Molecular Weight:300.81
IUPAC Name: 7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepine-2-thione
InChIKey: MWGWTOPCKLQYEU-UHFFFAOYSA-N
SMILES: S=C1N(C)C2=C(C(C3=CC=CC=C3)=NC1)C=C(Cl)C=C2
Biological Activity: Sulazepam, a benzodiazepine, is a selective ovarian cancer G protein-coupled receptor (OGR1) agonist. Sulazepam has anticonvulsive action and has the potential for airway hyperresponsiveness (AHR) research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sulazepam | 99.53% | Sulazepam, a benzodiazepine, is a selective ovarian cancer G protein-coupled receptor (OGR1) agonist. Sulazepam has anticonvulsive action and has the potential for airway hyperresponsiveness (AHR) research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sulazepam (Standard) | ≥98% | Sulazepam (Standard) is the analytical standard of Sulazepam (HY-105791). This product is intended for research and analytical applications. Sulazepam, a benzodiazepine, is a selective ovarian cancer G protein-coupled receptor (OGR1) agonist. Sulazepam has anticonvulsive action and has the potential for airway hyperresponsiveness (AHR) research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sulazepam-d5 | Sulazepam-d5 is a deuterium labeled Sulazepam (HY-105791). Sulazepam is a selective ovarian cancer G protein-coupled receptor (OGR1) agonist. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Ajay P Nayak, et al. OGR1-dependent regulation of the allergen-induced asthma phenotype. Am J Physiol Lung Cell Mol Physiol. 2021 Dec 1;321(6):L1044-L1054. [Content Brief]
- [2]. Tonio Pera, et al. Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines. FASEB J. 2018 Feb;32(2):862-874. [Content Brief]
